NVCR icon

NovoCure

128 hedge funds and large institutions have $778M invested in NovoCure in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
+24
Holders Change %
+23.08%
% of All Funds
2.91%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
34
Increased
43
Reduced
28
Closed
10
Calls
$20.2M
Puts
$4.47M
Net Calls
+$15.7M
Net Calls Change
-$3.94M
Name Holding Trade Value Shares
Change
Shares
Change %
EWM
126
Edge Wealth Management
New York
$1K +$1K +80 New
PCG
127
Private Capital Group
Connecticut
$16 +$16 +813 New
PC
128
PointState Capital
New York
-$14.9M -752,900 Closed
AC
129
Ascend Capital
California
-$13M -654,152 Closed
JG
130
Jefferies Group
New York
-$6.45M -325,000 Closed
MWNA
131
Marshall Wace North America
New York
-$4.15M -207,591 Closed
RGI
132
River Global Investors
United Kingdom
-$1.78M -89,451 Closed
DTL
133
Dynamic Technology Lab
Singapore
-$691K -34,828 Closed
NFA
134
Nationwide Fund Advisors
Ohio
-$637K -32,094 Closed
FRM
135
Fox Run Management
Connecticut
-$461K -23,200 Closed
AP
136
AHL Partners
United Kingdom
-$231K -11,639 Closed
FAM
137
Fred Alger Management
New York
-$20K -1,000 Closed